Liraglutide (TFA) is an agonist of the glucagon-like peptide 1 receptor (GLP-1). It activates GLP-1, leading to insulin secretion when glucose levels are elevated. Additionally, Liraglutide (TFA) reduces glucagon secretion in a glucose-dependent manner. This compound is utilized in research related to type 2 diabetes.
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
